001     150393
005     20220930130025.0
024 7 _ |a 10.1667/RR3239.1
|2 doi
024 7 _ |a 1938-5404
|2 ISSN
024 7 _ |a 0033-7587
|2 ISSN
024 7 _ |a WOS:000330992700004
|2 WOS
037 _ _ |a FZJ-2014-00452
082 _ _ |a 610
100 1 _ |a Schmitz, Sabine
|0 P:(DE-Juel1)133346
|b 0
|e Corresponding author
|u fzj
245 _ _ |a Chromosomal Radiosensitivity Analyzed by FISH in Lymphocytes of Prostate Cancer Patients and Healthy Donors
260 _ _ |a Great Falls, Va.
|c 2013
|b Radiation Research Society
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1421065264_25613
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a It is known that about 5–10% of cancer patients show severe clinical side effects during and after radiotherapy due to enhanced sensitivity to ionizing radiation. Identification of those radiosensitive individuals by a reliable in vitro assay before onset of treatment would have a great impact on successful radiotherapy. We compared the radiosensitivity of the chromosomes 2, 11 and 17 in prostate cancer patients with and without severe side effects after radiotherapy and in age-matched healthy donors. Each cohort consisted of at least 10 donors. Peripheral blood lymphocytes were irradiated ex vivo with 0.5, 1 und 2 Gy (137Cs γ rays). We investigated the radiosensitivity of the chromosomes 2, 11 and 17 by scoring of 100 FISH painted metaphases for each dose point and donor group. Statistical analyses were performed by nonparametric tests as Mann-Whitney test and Kruskal-Wallis ANOVA, paired Wilcoxon rank test, χ2 goodness-of-fit test and Spearman rank-order correlation at a significance level of P < 0.05. Analysis of the overall aberration yield revealed no significant differences between any donor groups. The translocation frequencies of the chromosomes 2, 11 and 17 coincided with their relative size. Thus, none of the chromosomes analyzed were more or less radiosensitive with respect to the genomic translocation frequency. Additionally, neither of the chromosomes showed enhanced or diminished radiosensitivity in one of the donor groups. Furthermore, variance analyses revealed that the distribution pattern of the aberrations per donor did not differ in each donor group even after exposure to 2 Gy. Prostate cancer patients with and without side effects cannot be distinguished from healthy donors based on aberration yield after irradiation with γ rays.
536 _ _ |a 899 - ohne Topic (POF2-899)
|0 G:(DE-HGF)POF2-899
|c POF2-899
|x 0
|f POF I
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
700 1 _ |a Brzozowska, Kinga
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Pinkawa, Michael
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Eble, Michael
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Kriehuber, Ralf
|0 P:(DE-Juel1)133469
|b 4
|u fzj
773 _ _ |a 10.1667/RR3239.1
|g Vol. 180, no. 5, p. 465 - 473
|0 PERI:(DE-600)2135113-2
|n 5
|p 465 - 473
|t Radiation research
|v 180
|y 2013
|x 1938-5404
909 C O |o oai:juser.fz-juelich.de:150393
|p VDB
|p OpenAPC
|p openCost
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-HGF)0
910 1 _ |a Forschungszentrum Jülich GmbH
|0 I:(DE-588b)5008462-8
|k FZJ
|b 4
|6 P:(DE-Juel1)133469
913 2 _ |a DE-HGF
|b Forschungsbereich Materie
|l Forschungsbereich Materie
|1 G:(DE-HGF)POF3-890
|0 G:(DE-HGF)POF3-899
|2 G:(DE-HGF)POF3-800
|v ohne Topic
|x 0
913 1 _ |a DE-HGF
|b Programmungebundene Forschung
|l ohne Programm
|1 G:(DE-HGF)POF2-890
|0 G:(DE-HGF)POF2-899
|2 G:(DE-HGF)POF2-800
|v ohne Topic
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
914 1 _ |y 2014
915 _ _ |a JCR/ISI refereed
|0 StatID:(DE-HGF)0010
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Thomson Reuters Master Journal List
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a National-Konsortium
|0 StatID:(DE-HGF)0430
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)S-US-20090406
|k S-US
|l Sicherheit und Strahlenschutz, Umgebungsüberwachung,Strahlenbiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)S-US-20090406
980 _ _ |a UNRESTRICTED
980 _ _ |a APC


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21